Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Sarcoma 1Other 1CNS 1

Conditions

Premature Birth 1Polycystic Ovary Syndrome 1Obesity 1Neoplasm Metastasis 1Gliosarcoma 1Glioblastoma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Utrogestan × Clear all
NCT05091866 2026-05-05

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Emory University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT04175002 2019-11-22

Endometrial Heparin-binding Epidermal Growth Factor Expression

National University of Malaysia

Unknown
40 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT00422526 2007-01-17

Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial

King's College Hospital NHS Trust

Phase 3 Completed
250 enrolled

Neoplasm Metastasis, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡